UK MHRA Notes Concern Over Medtech’s Mid-2023 Deadline

UK MHRA Notes Concern Over Medtech’s Mid-2023 Deadline – But Still No Draft Law Progress

21 Apr 2022

The One Agency initiative, patient safety, methods of funding and recruitment needs were pressing discussion themes during the MHRA’s April 2022 board meeting held in public.

The UK medtech industry keenly awaits news of any progress by the Medicines and Healthcare products Regulatory Agency (MHRA) on its written response to the UK CA marking consultation, held in autumn 2021.

The agency promised in its delivery plan to lay the new medical device statutory instrument by 31 March 2023, which...